Company news

Opthea Limited news in 2025

Opthea Limited's news releases, calls and decks from 2025, newest first.

View company

Investor Update Presentation

December 16, 2025

Opthea Receives A$10.8 million R&D Tax Incentive

October 5, 2025

S&P DJI Announces September 2025 Quarterly Rebalance

September 5, 2025

Preliminary Final Report

August 29, 2025

Corporate Update Investor Call

August 19, 2025

Opthea Provides Corporate Update

August 18, 2025

Continuation of Suspension from Quotation

March 31, 2025

Opthea Announces Decision to Discontinue Wet AMD Trials

March 31, 2025

Opthea Announces COAST Phase 3 Trial Topline Results

March 24, 2025

Voluntary suspension

March 18, 2025

Trading Halt

March 16, 2025

Opthea Announces Phase 2b Wet AMD Publication

March 3, 2025

Opthea Reports Half Year Results and Business Updates

February 28, 2025

Opthea Half Year Financial Report - Appendix 4D

February 27, 2025

Opthea Completes Drug Product PPQ Campaign

February 26, 2025

Opthea Completes COAST Final Week 52 Patient Visit

February 18, 2025

Opthea Investor Day

January 28, 2025

Opthea's Corporate Presentation - Jan 2025

January 13, 2025

Opthea Announces Publication in Diabetic Macular Edema

January 6, 2025

Decks in 2025